EUVIMEDEUVIMED entdecken
Fallbericht

Primary Pulmonary Angiosarcoma: A Case Report and Literature Review

Guzmán-Casta Jordi, Alatorre-Alexander Jorge Arturo, Carrasco-Cara Chards Sonia, Guzmán-Huesca Jorge, Riera-Sala Rodrigo, Sánchez-Ríos Carla Paola, Peña-Mirabal Erika Sagrario, Hernández-Dehesa Itzel Ariadna, Baltazar-Contreras Rocíodel Carmen, Martínez-Barrera Luis Manuel, Rodríguez-Cid Jerónimo Rafael

Journal of Medical Research and Surgery · 2020

DOI: 10.52916/jmrs204028 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Medical Research and Surgery, 2020. Verfasst von Guzmán-Casta Jordi und 10 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary sarcomas of the thorax are rare. They are classified according to their histologic features and constitute a large group of tumors that occur in the lung, mediastinum, pleura, and chest wall. Although primary thoracic sarcomas commonly manifest as large, heterogeneous masses, they have a wide spectrum of radiologic manifestations, including solitary pulmonary nodules, central endobronchial tumors, and intraluminal masses within the pulmonary arteries. Angiosarcomas are rare, malignant vascular tumors, representing about 2% of all soft tissue sarcomas. The most frequently primarily affected sites include the heart, liver, breast, skin, and scalp, and they have a high rate of metastases to the lungs and, less commonly, liver, regional lymph nodes, and bone. Definitive diagnosis is made based on histopathological and immunohistochemical findings. No standard treatment regimen has been established for pulmonary angiosarcoma. Radiation therapy, chemotherapy, surgical resection, and immunotherapy have been attempted. The use of radiation therapy in conjunction with surgery has resulted in local control and excellent functional and cosmetic outcome, for patients with angiosarcoma of the head and neck, but not the lung. For advanced-stage disease, other than the combination of doxorubicin and ifosfamide-based regimens, there have been few other chemotherapeutic options for the treatment of local or metastatic angiosarcoma.

Zitieren

APA

Jordi, G., Arturo, A. J., Sonia, C. C., Jorge, G., Rodrigo, R., Paola, S. C., Sagrario, P. E., Ariadna, H. I., Carmen, B. R., Manuel, M. L., & Rafael, R. J. (2020). Primary Pulmonary Angiosarcoma: A Case Report and Literature Review. Journal of Medical Research and Surgery. https://doi.org/10.52916/jmrs204028

Vancouver

Jordi G, Arturo AJ, Sonia CC, Jorge G, Rodrigo R, Paola SC, et al. Primary Pulmonary Angiosarcoma: A Case Report and Literature Review. Journal of Medical Research and Surgery. 2020. doi:10.52916/jmrs204028

BibTeX
@article{Jordi2020,
  author = {Jordi, Guzmán-Casta and Arturo, Alatorre-Alexander Jorge and Sonia, Carrasco-Cara Chards and Jorge, Guzmán-Huesca and Rodrigo, Riera-Sala and Paola, Sánchez-Ríos Carla and Sagrario, Peña-Mirabal Erika and Ariadna, Hernández-Dehesa Itzel and Carmen, Baltazar-Contreras Rocíodel and Manuel, Martínez-Barrera Luis and Rafael, Rodríguez-Cid Jerónimo},
  title = {Primary Pulmonary Angiosarcoma: A Case Report and Literature Review},
  journal = {Journal of Medical Research and Surgery},
  year = {2020},
  doi = {10.52916/jmrs204028}
}
Kostenlos starten →